drugset / Trial / NCT02570412

Compassionate Use of Aldoxorubicin in Sarcoma Patients Chemotherapy

NCT02570412 ↗

Expanded access No longer available CytRx

Summary

Compassionate use of aldoxorubicin in sarcoma patients who have failed prior chemotherapy.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Aldoxorubicin Small molecule 350 mg/m2 —

Indications